慢性日光损伤皮肤上的黑色素瘤:恶性雀斑样痣与促纤维增生性黑色素瘤
本文聚焦于慢性日光损伤皮肤上的黑色素瘤(MSDS),包括恶性雀斑样痣和促纤维增生性黑色素瘤。文章讨论了两者的病因、有助于准确识别这些病变的新兴诊断辅助手段,以及两者常共同出现的临床意义。文章还探讨了切缘评估、切除及非手术治疗在MSDS管理中的挑战,并讨论了免疫治疗在侵袭性疾病中的作用。
要点
- MSDS与慢性紫外线暴露独特相关,具有不同于间歇性日晒或防晒部位黑色素瘤的遗传特征
- 恶性雀斑样痣与促纤维增生性黑色素瘤常共同出现,诊断时需注意识别
- MSDS管理面临切缘评估、切除及非手术治疗选择等挑战
核心结论
- MSDS(包括恶性雀斑样痣和促纤维增生性黑色素瘤)具有独特的遗传特征,与慢性紫外线暴露独特相关
- 将MSDS与间歇性日晒或防晒部位发生的黑色素瘤区分开来,最终有助于优化患者结局
主要发现
- 存在多种遗传学上不同的通路可导致黑色素瘤
- MSDS具有独特的遗传特征,与慢性紫外线暴露独特相关
- 恶性雀斑样痣和促纤维增生性黑色素瘤常共同出现,具有独特和重叠的特征
- MSDS管理中的挑战包括切缘评估、切除以及非手术治疗的潜在作用
- 免疫治疗在侵袭性疾病中发挥作用
临床怎么用
- 了解MSDS与间歇性日晒或防晒部位黑色素瘤的区别,有助于优化患者结局
- 新兴诊断辅助手段可能有助于准确识别恶性雀斑样痣和促纤维增生性黑色素瘤
- 临床管理中需关注切缘评估、切除方式选择及非手术治疗的潜在作用
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
There are multiple, genetically distinct pathways that give rise to melanoma. Melanomas on sun-damaged skin (MSDS), including lentigo maligna and desmoplastic melanoma, have distinct genetic profiles and are uniquely linked to chronic ultraviolet exposure. In this article, we discuss the etiologies of lentigo maligna and desmoplastic melanoma, emerging diagnostic adjuncts that might be helpful for accurately identifying these lesions, and the clinical relevance of their frequent co-occurrence. We present unique and overlapping features of these entities and discuss challenges in MSDS management, including margin assessment, excision, and the potential role of nonsurgical therapy. Last, we address the role of immunotherapy in invasive disease. Understanding MSDS as distinct from melanoma arising on intermittently sun-exposed or sun-protected skin will ultimately help optimize patient outcomes.
引用
- DeWane ME, Kelsey A, Oliviero M, et al. Melanoma on chronically sun-damaged skin: Lentigo maligna and desmoplastic melanoma. J Am Acad Dermatol. 2019. PMID: 30930085. doi:10.1016/j.jaad.2019.03.066
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。